Anna Schuh, MD, PhD, FRCP, FRCPath

Director of Molecular Diagnostics (Oxford Molecular Diagnostic Centre), Professor of Molecular Diagnostics (Department of Oncology)
Oxford Molecular Diagnostic Centre, Department of Oncology, University of Oxford, United Kingdom

Anna Schuh, MD, PhD, FRCP, FRCPath
Professor of Molecular Diagnostics
Department of Oncology, University of Oxford
Interest in CLL genomics
Principle Investigator of >50 early/late phase clinical trials in CLL
Led the UK clinical trial collaborative group for 4 years
Board member of the iwCLL where she chairs the Global Partnership Subcommittee
Directs Oxford Master Programme in Global Precision Cancer Medicine
Co-founder of SerenOx, a social enterprise to improve access to diagnostics in Africa.

Poster(s):

• 1202 - T cell type abundance and gene expression patterns in the context of clinical progression of treatment-naïve CLL/MBL patients from the OxPLoreD study

• 3001 - Sequencing of circulating tumour DNA reveals additional driver mutations in Richter Transformation

• 3006 - High-risk International Prognostic Score for early asymptomatic CLL (IPS-E) identifies chronic lymphocytic leukaemia at risk of progression to treatment in the OXPLORED study, a prospective observational study for early lymphoproliferative disease